You just read:

Processa Pharmaceuticals Receives Orphan Designation Status For PCS499 In Necrobiosis Lipoidica From The Food And Drug Administration (FDA)

News provided by

Processa Pharmaceuticals, Inc.

Jun 22, 2018, 09:00 ET